Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for MRUS

Stock NameMerus BV
TickerMRUS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINNL0011606264

Show aggregate MRUS holdings

News associated with MRUS

Merus N.V. (NASDAQ:MRUS) Receives Average Recommendation of “Buy” from Analysts
Merus N.V. (NASDAQ:MRUS – Get Free Report) has received an average recommendation of “Buy” from the twelve research firms that are covering the firm, Marketbeat.com reports. Eleven analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that […] - 2025-09-04 03:06:58
Merus (NASDAQ:MRUS) Coverage Initiated at Alliance Global Partners
Research analysts at Alliance Global Partners started coverage on shares of Merus (NASDAQ:MRUS – Get Free Report) in a research note issued on Monday, MarketBeat reports. The firm set a “buy” rating and a $90.00 price target on the biotechnology company’s stock. Alliance Global Partners’ target price suggests a potential upside of 34.61% from the […] - 2025-08-27 02:30:45
Leerink Partnrs Estimates Merus’ Q3 Earnings (NASDAQ:MRUS)
Merus N.V. (NASDAQ:MRUS – Free Report) – Analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for Merus in a report issued on Wednesday, August 6th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of ($1.50) for the quarter, down from their prior estimate of ($1.32). […] - 2025-08-12 02:46:48
Merus (NASDAQ:MRUS) Downgraded to Sell Rating by Wall Street Zen
Merus (NASDAQ:MRUS – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Sunday. A number of other research analysts have also issued reports on the company. Needham & Company LLC reiterated a “buy” rating and set a $75.00 […] - 2025-07-22 02:07:06
Wall Street Zen Upgrades Merus (NASDAQ:MRUS) to “Hold”
Merus (NASDAQ:MRUS – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday. A number of other brokerages have also issued reports on MRUS. William Blair reaffirmed an “outperform” rating on shares of Merus in a research report on […] - 2025-07-14 03:40:50
Insider Selling: Merus N.V. (NASDAQ:MRUS) COO Sells $1,793,840.00 in Stock
Merus N.V. (NASDAQ:MRUS – Get Free Report) COO Peter B. Silverman sold 34,000 shares of the firm’s stock in a transaction dated Friday, June 20th. The shares were sold at an average price of $52.76, for a total value of $1,793,840.00. The sale was disclosed in a legal filing with the SEC, which is accessible […] - 2025-06-27 05:10:52
Merus N.V. (NASDAQ:MRUS) Receives $84.64 Average Price Target from Brokerages
Merus N.V. (NASDAQ:MRUS – Get Free Report) has been assigned a consensus rating of “Buy” from the fourteen analysts that are currently covering the firm, MarketBeat reports. Twelve equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year target price […] - 2025-06-24 02:36:57
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 14,544 Shares of Merus (NASDAQ:MRUS)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Merus (NASDAQ:MRUS – Free Report) by 17.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 98,744 shares of the biotechnology company’s stock after purchasing an additional 14,544 shares […] - 2025-06-05 05:13:00
Merus Prices 5.26 Mln Shares At $57/Shr In Public Offering; To Raise Around $300 Mln
(RTTNews) - Merus N.V. (MRUS), a Dutch oncology company developing multispecific antibodies and antibody drug conjugates, Wednesday announced the pricing of an underwritten public offering of around 5.26 million shares, at a price of $57.00 per share. The gross proceeds from the - 2025-06-04 01:56:43
Merus N.V. Announces Pricing of $300 Million Public Offering of Common Shares
Merus N.V. announced a $300 million public offering of 5.26 million common shares to fund clinical development and research. - 2025-06-04 01:20:22
Analysts Anticipate 25% Gains Ahead For The Holdings of FHLC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-29 08:03:59
Merus (NASDAQ:MRUS) Earns Buy Rating from Needham & Company LLC
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $75.00 target price on the biotechnology company’s stock. Needham & Company LLC’s price target points to a potential upside […] - 2025-05-21 03:03:18
Merus (NASDAQ:MRUS) Holdings Decreased by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company reduced its stake in shares of Merus (NASDAQ:MRUS – Free Report) by 17.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,085 shares of the biotechnology company’s stock after selling 9,204 shares during the quarter. […] - 2025-05-12 05:36:50
Tudor Investment Corp ET AL Purchases Shares of 5,075 Merus (NASDAQ:MRUS)
Tudor Investment Corp ET AL bought a new stake in Merus (NASDAQ:MRUS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,075 shares of the biotechnology company’s stock, valued at approximately $213,000. A number of other institutional investors and hedge […] - 2025-05-11 05:44:52
Tower Research Capital LLC TRC Decreases Stock Holdings in Merus (NASDAQ:MRUS)
Tower Research Capital LLC TRC decreased its stake in shares of Merus (NASDAQ:MRUS – Free Report) by 77.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,668 shares of the biotechnology company’s stock after selling 9,221 shares during the […] - 2025-05-09 05:21:09
Merus (NASDAQ:MRUS) Short Interest Update
Merus (NASDAQ:MRUS – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 6,270,000 shares, a decrease of 15.5% from the March 31st total of 7,420,000 shares. Currently, 9.6% of the company’s shares are sold short. Based on […] - 2025-05-05 04:58:56
Merus (NASDAQ:MRUS) Earns “Outperform” Rating from William Blair
William Blair reaffirmed their outperform rating on shares of Merus (NASDAQ:MRUS – Free Report) in a report issued on Monday morning,RTT News reports. Several other analysts have also commented on the stock. Guggenheim reissued a “buy” rating and set a $109.00 target price on shares of Merus in a research note on Friday, March 28th. […] - 2025-04-29 04:54:48
Invesco Ltd. Grows Stock Position in Merus (NASDAQ:MRUS)
Invesco Ltd. lifted its holdings in Merus (NASDAQ:MRUS – Free Report) by 2.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 786,365 shares of the biotechnology company’s stock after purchasing an additional 16,712 shares during the period. Invesco Ltd. owned about 1.15% of Merus […] - 2025-04-18 05:18:50
HighTower Advisors LLC Has $337,000 Stock Position in Merus (NASDAQ:MRUS)
HighTower Advisors LLC lifted its position in Merus (NASDAQ:MRUS – Free Report) by 10.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,020 shares of the biotechnology company’s stock after buying an additional 789 shares during the period. HighTower […] - 2025-04-02 04:14:47
Guggenheim Reiterates Buy Rating for Merus (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a report issued on Tuesday,Benzinga reports. They presently have a $109.00 target price on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 131.91% from the company’s previous close. Other research analysts also recently […] - 2025-03-20 04:55:00
Bank of America Has Lowered Expectations for Merus (NASDAQ:MRUS) Stock Price
Merus (NASDAQ:MRUS – Get Free Report) had its target price lowered by analysts at Bank of America from $73.00 to $70.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price objective indicates a potential upside of 47.12% from the […] - 2025-03-12 04:00:48
HC Wainwright Reaffirms “Buy” Rating for Merus (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $85.00 price objective on the biotechnology company’s stock. HC Wainwright’s price target would suggest a potential upside of 90.41% from the stock’s previous close. […] - 2025-03-05 04:32:51
William Blair Predicts Merus’ FY2028 Earnings (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Free Report) – William Blair issued their FY2028 EPS estimates for Merus in a report issued on Friday, February 28th. William Blair analyst M. Phipps expects that the biotechnology company will post earnings per share of ($3.58) for the year. William Blair has a “Outperform” rating on the stock. The consensus estimate […] - 2025-03-04 06:28:57
Merus (NASDAQ:MRUS) Given New $83.00 Price Target at Needham & Company LLC
Merus (NASDAQ:MRUS – Free Report) had its price objective lowered by Needham & Company LLC from $85.00 to $83.00 in a research note released on Friday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other equities analysts have also recently commented on the company. The Goldman […] - 2025-03-03 04:54:51
Merus (NASDAQ:MRUS) Shares Purchased by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D grew its holdings in shares of Merus (NASDAQ:MRUS – Free Report) by 29.0% during the 4th quarter, HoldingsChannel reports. The firm owned 48,268 shares of the biotechnology company’s stock after buying an additional 10,842 shares during the period. State of New Jersey Common Pension Fund D’s holdings […] - 2025-02-24 06:42:49
Analysts Set Merus (NASDAQ:MRUS) PT at $85.92
Shares of Merus (NASDAQ:MRUS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the sixteen research firms that are covering the stock, MarketBeat reports. Fourteen equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […] - 2025-02-19 04:46:55
KBC Group NV Has $2.41 Million Stake in Merus (NASDAQ:MRUS)
KBC Group NV raised its position in Merus (NASDAQ:MRUS – Free Report) by 4,583.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,234 shares of the biotechnology company’s stock after purchasing an additional 56,012 shares during the quarter. KBC Group NV’s holdings in […] - 2025-02-02 07:28:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc MRUS holdings

DateNumber of MRUS Shares HeldBase Market Value of MRUS SharesLocal Market Value of MRUS SharesChange in MRUS Shares HeldChange in MRUS Base ValueCurrent Price per MRUS Share HeldPrevious Price per MRUS Share Held
2025-11-12 (Wednesday)26,331MRUS holding decreased by -86USD 2,528,829MRUS holding increased by 6534USD 2,528,829-86USD 6,534 USD 96.04 USD 95.48
2025-11-11 (Tuesday)26,417USD 2,522,295MRUS holding increased by 1585USD 2,522,2950USD 1,585 USD 95.48 USD 95.42
2025-11-10 (Monday)26,417USD 2,520,710MRUS holding increased by 5019USD 2,520,7100USD 5,019 USD 95.42 USD 95.23
2025-11-07 (Friday)26,417USD 2,515,691MRUS holding increased by 1849USD 2,515,6910USD 1,849 USD 95.23 USD 95.16
2025-11-06 (Thursday)26,417MRUS holding decreased by -86USD 2,513,842MRUS holding decreased by -8714USD 2,513,842-86USD -8,714 USD 95.16 USD 95.18
2025-11-05 (Wednesday)26,503MRUS holding decreased by -860USD 2,522,556MRUS holding decreased by -78024USD 2,522,556-860USD -78,024 USD 95.18 USD 95.04
2025-11-04 (Tuesday)27,363MRUS holding decreased by -172USD 2,600,580MRUS holding decreased by -9187USD 2,600,580-172USD -9,187 USD 95.04 USD 94.78
2025-11-03 (Monday)27,535MRUS holding decreased by -172USD 2,609,767MRUS holding decreased by -18519USD 2,609,767-172USD -18,519 USD 94.78 USD 94.86
2025-10-31 (Friday)27,707USD 2,628,286MRUS holding decreased by -5541USD 2,628,2860USD -5,541 USD 94.86 USD 95.06
2025-10-30 (Thursday)27,707USD 2,633,827MRUS holding increased by 6926USD 2,633,8270USD 6,926 USD 95.06 USD 94.81
2025-10-29 (Wednesday)27,707USD 2,626,901MRUS holding decreased by -2493USD 2,626,9010USD -2,493 USD 94.81 USD 94.9
2025-10-28 (Tuesday)27,707MRUS holding increased by 258USD 2,629,394MRUS holding increased by 32719USD 2,629,394258USD 32,719 USD 94.9 USD 94.6
2025-10-27 (Monday)27,449USD 2,596,675MRUS holding decreased by -7686USD 2,596,6750USD -7,686 USD 94.6 USD 94.88
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRUS by Blackrock for IE00B3VWM098

Show aggregate share trades of MRUS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-8696.08595.590 95.639USD -8,225 54.41 Loss of -3,546 on sale
2025-11-06SELL-8695.34095.020 95.052USD -8,174 53.56 Loss of -3,568 on sale
2025-11-05SELL-86095.20094.920 94.948USD -81,655 53.35 Loss of -35,777 on sale
2025-11-04SELL-17295.08094.760 94.792USD -16,304 53.13 Loss of -7,166 on sale
2025-11-03SELL-17294.90094.750 94.765USD -16,300 52.91 Loss of -7,199 on sale
2025-10-28BUY25894.90094.960 94.954USD 24,498 52.01
2025-10-24SELL-8694.88095.060 95.042USD -8,174 51.54 Loss of -3,741 on sale
2025-10-15BUY51694.95094.960 94.959USD 48,999 49.84
2025-10-02BUY8694.15094.390 94.366USD 8,115 49.33
2025-09-30BUY17294.15094.295 94.280USD 16,216 48.81
2025-09-11BUY34469.80070.647 70.562USD 24,273 48.07
2025-08-21SELL-7266.65066.930 66.902USD -4,817 47.96 Loss of -1,364 on sale
2025-07-31BUY21666.24067.590 67.455USD 14,570 47.75
2025-06-30SELL-14452.60053.995 53.855USD -7,755 46.40 Loss of -1,074 on sale
2025-06-25SELL-7253.88054.630 54.555USD -3,928 46.25 Loss of -598 on sale
2025-06-20SELL-14453.10553.310 53.290USD -7,674 46.10 Loss of -1,035 on sale
2025-05-26BUY72 55.140* 44.69
2025-05-19SELL-7241.36042.208 42.123USD -3,033 44.68 Profit of 184 on sale
2025-05-15SELL-21940.08041.730 41.565USD -9,103 44.74 Profit of 696 on sale
2025-05-12SELL-7342.41043.370 43.274USD -3,159 44.84 Profit of 114 on sale
2025-05-09SELL-7340.90044.220 43.888USD -3,204 44.87 Profit of 72 on sale
2025-04-30SELL-7345.51045.800 45.771USD -3,341 45.01 Loss of -56 on sale
2025-04-24SELL-14644.36044.435 44.428USD -6,486 45.03 Profit of 88 on sale
2025-04-17SELL-7343.05543.215 43.199USD -3,154 45.14 Profit of 142 on sale
2025-04-15SELL-21943.22043.460 43.436USD -9,512 45.20 Profit of 386 on sale
2025-04-14SELL-21942.43042.570 42.556USD -9,320 45.23 Profit of 585 on sale
2025-04-09SELL-29239.56040.000 39.956USD -11,667 45.41 Profit of 1,591 on sale
2025-04-07SELL-51137.39037.620 37.597USD -19,212 45.62 Profit of 4,100 on sale
2025-04-04SELL-73038.11040.690 40.432USD -29,515 45.71 Profit of 3,852 on sale
2025-03-31BUY7342.09045.440 45.105USD 3,293 45.86
2025-03-19SELL-14647.00047.975 47.877USD -6,990 45.79 Loss of -305 on sale
2025-03-14SELL-43847.10049.250 49.035USD -21,477 45.74 Loss of -1,442 on sale
2025-03-13SELL-14647.64049.880 49.656USD -7,250 45.71 Loss of -575 on sale
2025-03-12SELL-2,48249.16049.710 49.655USD -123,244 45.66 Loss of -9,904 on sale
2025-03-07SELL-14646.07047.210 47.096USD -6,876 45.61 Loss of -216 on sale
2025-03-06SELL-21946.10047.420 47.288USD -10,356 45.61 Loss of -368 on sale
2025-03-03SELL-7345.47047.430 47.234USD -3,448 45.61 Loss of -118 on sale
2025-02-28SELL-17,47747.09047.670 47.612USD -832,115 45.59 Loss of -35,370 on sale
2025-02-26SELL-11845.53047.040 46.889USD -5,533 45.58 Loss of -155 on sale
2025-02-25SELL-35444.40046.700 46.470USD -16,450 45.60 Loss of -308 on sale
2025-02-18BUY59042.27043.100 43.017USD 25,380 45.58
2025-02-13BUY11840.30041.145 41.061USD 4,845 45.90
2025-02-12BUY11840.26040.450 40.431USD 4,771 46.01
2025-02-11BUY35440.11040.660 40.605USD 14,374 46.14
2025-02-06BUY1,06241.54043.350 43.169USD 45,845 46.47
2025-01-27BUY11840.40041.675 41.547USD 4,903 47.68
2024-12-30BUY59041.89042.385 42.335USD 24,978 48.41
2024-12-06BUY47244.65045.600 45.505USD 21,478 48.87
2024-12-05BUY11843.86046.924 46.618USD 5,501 49.04
2024-12-04BUY59045.48546.866 46.728USD 27,569 49.17
2024-11-29BUY59044.84045.880 45.776USD 27,008 49.49
2024-11-27BUY46844.97046.010 45.906USD 21,484 49.88
2024-11-26BUY11745.87047.180 47.049USD 5,505 50.06
2024-11-21BUY58544.35545.760 45.619USD 26,687 50.85
2024-11-20BUY35142.93043.520 43.461USD 15,255 51.29
2024-11-18BUY1,40444.27046.820 46.565USD 65,377 52.22
2024-11-12BUY93651.63052.830 52.710USD 49,337 52.25
2024-11-08BUY58554.50054.900 54.860USD 32,093 52.09
2024-11-07BUY1,75554.50055.390 55.301USD 97,053 51.91
2024-11-06BUY23453.13053.350 53.328USD 12,479 51.81
2024-10-31BUY11749.93050.877 50.782USD 5,942 52.31
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRUS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19123,75515,565295,32441.9%
2025-09-1897,3164,160228,73742.5%
2025-09-17144,3271,098242,46559.5%
2025-09-16109,9602,131222,43449.4%
2025-09-15149,8900318,67947.0%
2025-09-12313,4555,537606,03651.7%
2025-09-11186,04117,755345,08153.9%
2025-09-1077,2990149,18451.8%
2025-09-09109,27712,250231,07547.3%
2025-09-08110,3000207,99053.0%
2025-09-05113,7432,003270,19242.1%
2025-09-0471,3900194,43536.7%
2025-09-03118,2361,764269,03743.9%
2025-09-02104,542485304,73834.3%
2025-08-2988,408602208,72042.4%
2025-08-28205,6791,769570,45436.1%
2025-08-2743,7270107,17140.8%
2025-08-2649,2210280,42017.6%
2025-08-2551,1610113,71745.0%
2025-08-22100,1567,575192,11152.1%
2025-08-2172,4115,956216,04233.5%
2025-08-2059,6600265,38522.5%
2025-08-1994,8490242,81639.1%
2025-08-1849,3072,689113,53643.4%
2025-08-1564,98410,335112,73357.6%
2025-08-1476,8440278,92427.6%
2025-08-13178,5061,001423,47642.2%
2025-08-1286,7181,133254,30134.1%
2025-08-1184,695390117,68072.0%
2025-08-08112,4221,666230,83448.7%
2025-08-07130,196179222,63858.5%
2025-08-06255,4360409,27962.4%
2025-08-05102,3195,000286,82235.7%
2025-08-0443,196067,78863.7%
2025-08-01111,3330277,02240.2%
2025-07-31164,449300435,71737.7%
2025-07-30114,7390179,11064.1%
2025-07-2969,9870152,83345.8%
2025-07-28117,8630253,63746.5%
2025-07-25170,5300303,99956.1%
2025-07-24254,6644,904482,53052.8%
2025-07-23145,1700217,50366.7%
2025-07-22139,563525302,77646.1%
2025-07-21287,1341,374573,96150.0%
2025-07-18269,9230465,09658.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.